Home / Auditor changes / Calidi Biotherapeutics, Inc.
Filed 2025-05-02 路 Form 8-K 路 Accession 0001641172-25-008365 nano
Price before filing: $92.8 (2025-05-01 close, split/dividend-adjusted)
Market cap at flag: $17.2M (2025-05-02) 路 Latest: $1.2M (2026-10-16)
| Window | CLDI | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -28.4% | +6.1% | -34.6% | 2025-06-02 |
| 90 days | +23.3% | +13.5% | +9.8% | 2025-07-31 |
| 180 days | -74.3% | +23.8% | -98.1% | 2025-10-29 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"Accordingly, on April 30, 2025, as a result of the acquisition, Marcum resigned as the independent registered public accounting firm of Calidi Biotherapeutics, Inc."
Quoted from the filing. Source
The company changed its outside auditor (8-K Item 4.01). A dismissal or resignation, especially near an annual report or with reported disagreements, is a warning sign. Changes caused by audit firms merging are usually routine.
Type: routine (audit-firm merger)
Disagreements reported: no
Former auditor: Marcum LLP · New auditor: CBIZ CPAs P.C.
Why this score: routine: audit firm merged/was acquired; also within 90 days: Going-concern doubt
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.